Logo image of FPH

FIVE POINT HOLDINGS LLC-CL A (FPH) Stock Fundamental Analysis

NYSE:FPH - New York Stock Exchange, Inc. - US33833Q1067 - Common Stock - Currency: USD

5.75  +1.69 (+41.63%)

After market: 5.7101 -0.04 (-0.69%)

Fundamental Rating

4

FPH gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 63 industry peers in the Real Estate Management & Development industry. FPH has only an average score on both its financial health and profitability. FPH has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year FPH was profitable.
In the past year FPH had a positive cash flow from operations.
In multiple years FPH reported negative net income over the last 5 years.
In the past 5 years FPH reported 4 times negative operating cash flow.
FPH Yearly Net Income VS EBIT VS OCF VS FCFFPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M -300M

1.2 Ratios

With a decent Return On Assets value of 1.74%, FPH is doing good in the industry, outperforming 73.77% of the companies in the same industry.
FPH has a better Return On Equity (7.31%) than 81.97% of its industry peers.
FPH has a better Return On Invested Capital (1.39%) than 63.93% of its industry peers.
Industry RankSector Rank
ROA 1.74%
ROE 7.31%
ROIC 1.39%
ROA(3y)0.51%
ROA(5y)0.37%
ROE(3y)2.21%
ROE(5y)1.61%
ROIC(3y)N/A
ROIC(5y)N/A
FPH Yearly ROA, ROE, ROICFPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10

1.3 Margins

FPH has a Profit Margin of 26.09%. This is amongst the best in the industry. FPH outperforms 96.72% of its industry peers.
FPH has a Operating Margin of 23.84%. This is amongst the best in the industry. FPH outperforms 91.80% of its industry peers.
With a decent Gross Margin value of 49.29%, FPH is doing good in the industry, outperforming 78.69% of the companies in the same industry.
In the last couple of years the Gross Margin of FPH has declined.
Industry RankSector Rank
OM 23.84%
PM (TTM) 26.09%
GM 49.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.06%
GM growth 5Y-2.19%
FPH Yearly Profit, Operating, Gross MarginsFPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200

More info and screens

4

2. Health

2.1 Basic Checks

FPH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
FPH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FPH Yearly Shares OutstandingFPH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M
FPH Yearly Total Debt VS Total AssetsFPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

FPH has an Altman-Z score of 1.21. This is a bad value and indicates that FPH is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.21, FPH perfoms like the industry average, outperforming 45.90% of the companies in the same industry.
The Debt to FCF ratio of FPH is 28.26, which is on the high side as it means it would take FPH, 28.26 years of fcf income to pay off all of its debts.
FPH has a better Debt to FCF ratio (28.26) than 70.49% of its industry peers.
A Debt/Equity ratio of 0.83 indicates that FPH is somewhat dependend on debt financing.
FPH's Debt to Equity ratio of 0.83 is in line compared to the rest of the industry. FPH outperforms 40.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 28.26
Altman-Z 1.21
ROIC/WACC0.16
WACC8.5%
FPH Yearly LT Debt VS Equity VS FCFFPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M

2.3 Liquidity

FPH has a Current Ratio of 9.06. This indicates that FPH is financially healthy and has no problem in meeting its short term obligations.
FPH has a better Current ratio (9.06) than 90.16% of its industry peers.
A Quick Ratio of 0.79 indicates that FPH may have some problems paying its short term obligations.
FPH has a Quick ratio of 0.79. This is in the lower half of the industry: FPH underperforms 68.85% of its industry peers.
Industry RankSector Rank
Current Ratio 9.06
Quick Ratio 0.79
FPH Yearly Current Assets VS Current LiabilitesFPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.00% over the past year.
EPS 1Y (TTM)28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%34.55%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FPH Yearly Revenue VS EstimatesFPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
FPH Yearly EPS VS EstimatesFPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.99, which indicates a rather cheap valuation of FPH.
Based on the Price/Earnings ratio, FPH is valued cheaply inside the industry as 93.44% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.58, FPH is valued rather cheaply.
Industry RankSector Rank
PE 5.99
Fwd PE N/A
FPH Price Earnings VS Forward Price EarningsFPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, FPH is valued cheaper than 90.16% of the companies in the same industry.
86.89% of the companies in the same industry are more expensive than FPH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.23
EV/EBITDA 10.89
FPH Per share dataFPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FPH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FIVE POINT HOLDINGS LLC-CL A

NYSE:FPH (1/24/2025, 8:04:00 PM)

After market: 5.7101 -0.04 (-0.69%)

5.75

+1.69 (+41.63%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)01-23 2025-01-23/amc
Earnings (Next)N/A N/A
Inst Owners59.2%
Inst Owner Change0.03%
Ins Owners4.94%
Ins Owner Change-0.02%
Market Cap398.94M
Analysts80
Price TargetN/A
Short Float %0.34%
Short Ratio0.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.99
Fwd PE N/A
P/S 2.03
P/FCF 19.23
P/OCF 18.6
P/B 0.57
P/tB 0.58
EV/EBITDA 10.89
EPS(TTM)0.96
EY16.7%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.3
FCFY5.2%
OCF(TTM)0.31
OCFY5.38%
SpS2.84
BVpS10.13
TBVpS9.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.74%
ROE 7.31%
ROCE 1.76%
ROIC 1.39%
ROICexc 1.52%
ROICexgc 1.53%
OM 23.84%
PM (TTM) 26.09%
GM 49.29%
FCFM 10.54%
ROA(3y)0.51%
ROA(5y)0.37%
ROE(3y)2.21%
ROE(5y)1.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.06%
GM growth 5Y-2.19%
F-Score7
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 28.26
Debt/EBITDA 8.39
Cap/Depr 3.07%
Cap/Sales 0.36%
Interest Coverage 0.92
Cash Conversion 30.69%
Profit Quality 40.38%
Current Ratio 9.06
Quick Ratio 0.79
Altman-Z 1.21
F-Score7
WACC8.5%
ROIC/WACC0.16
Cap/Depr(3y)0.39%
Cap/Depr(5y)4.9%
Cap/Sales(3y)0.09%
Cap/Sales(5y)0.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%34.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y652.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y122.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y122.79%
OCF growth 3YN/A
OCF growth 5YN/A